SEGMENT REPORTING
The Company operates as a single reportable segment, infusion services. Infusion services derives revenue through the clinical management of infusion therapy, nursing support, and care coordination in order to provide solutions to complex patient conditions in the home or other nonhospital settings. The Company’s infusion services segment activities are managed on a consolidated basis and therapies are distributed and administered in a similar manner.
Operating segments have been identified based on the financial information utilized by the Company’s Chief Executive Officer, the chief operating decision maker (“CODM”). The CODM uses net income as a measure of profitability to assess segment performance and deciding on how to allocate resources such as capital investments, share repurchases, and acquisitions. The CODM does not use or receive total assets by segment to make decisions regarding resources; therefore, the total asset disclosure by segment has not been included.
The following table reflects results of operations of the Company’s reportable segment (in thousands):
Year Ended December 31,
202520242023
Infusion services net revenue$5,555,778 $4,911,591 $4,222,656 
Other revenue (1)93,741 86,611 79,668 
Total Option Care Health revenue5,649,519 4,998,202 4,302,324 
(Expense) Income:
Cost of net revenues - drugs(3,984,955)(3,446,735)(2,812,531)
Salaries, benefits, and other employee expense(848,996)(787,922)(760,499)
Other segment items (2)(410,124)(380,803)(355,498)
Depreciation and amortization expense(67,538)(60,909)(59,201)
Interest expense, net(54,558)(49,029)(51,248)
Equity in earnings of joint ventures7,409 5,964 5,530 
Other, net(7,857)4,831 89,865 
Income tax expense(75,315)(71,776)(91,652)
Net Income$207,585 $211,823 $267,090 
(1) Represents business activities related to other miscellaneous revenue streams.
(2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.

Historical Timeline

Fiscal YearFiled
2025Feb 24, 2026Showing above
2024Feb 26, 2025
2015Mar 3, 2016

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.